Checklist For CTD Pre Submission Screening

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Checklist for CTD Pre-Submission Screening Doc PE&R/LST/AR/001 Ver 01

CTD PRE-SUBMISSION SCREENING CHECKLIST


Note: Application shall be received for detailed evaluation if all the below mentioned documents
are submitted.
1. Form 5-F: Yes No

2. Requisite fee: Yes No

3. Valid DML / DSL: Yes No

4. Evidence of GMP compliance of relevant section: Yes No

5. Evidence of approval status in RRA: Yes No

6. QOS (Quality Overall Summary) as per WHO QOS-PD Template: Yes No

For Module-3, in Drug Substance Part:


3.2.S.2.1: Manufacturer(s) site address Yes No
3.2.S.4.4: Certificate of Analysis (COA) of both drug substance(s) manufacturer Yes No
and drug product manufacturer:
3.2.S.7: Stability data of 3 batches at accelerated and real time conditions: Yes No
For Module-3, in Drug Product Part:
3.2.P.2.2.1: Product development, description of dosage form, Pharmaceutical Yes No
Equivalence through Comparative Dissolution Profile (where applicable)
[Explanation: Pharmaceutical Equivalence is mandatory for each dosage
form/product while Comparative Dissolution Profile is required as
applicable]
3.2.P.3.5: Process validation: Yes No
3.2.P.5.1: Specifications of drug product: Yes No
3.2.P.5.3: Validation / verification of analytical procedures summary / reports: Yes No
3.2.P.8.3: Stability data: Yes No
FOR IMPORTED PRODUCTS (Following additional documents)
Original, legalized and valid CoPP / Free sale and GMP certificate Yes No
Sole agency agreement / authorization letter Yes No
Remarks (if any):
_________________________________________________________________________________
_________________________________________________________________________________

Received Returned back to applicant for completion

Page 1 of 2
Checklist for CTD Pre-Submission Screening Doc PE&R/LST/AR/001 Ver 01
#

Date Name & Signature

Page 2 of 2

You might also like